Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cells.
about
Early priming minimizes the age-related immune compromise of CD8⁺ T cell diversity and functionSang Froid in a time of trouble: is a vaccine against HIV possible?Consequences of suboptimal priming are apparent for low-avidity T-cell responses.HIV vaccination: turning the spotlight on effector memory T cells as mucosal gatekeepers.Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy.Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats.Immune escape mutations detected within HIV-1 epitopes associated with viral control during treatment interruptionEarly and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressorsImmunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents.AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein.The efficiency of the human CD8+ T cell response: how should we quantify it, what determines it, and does it matter?Immunodominant HIV-1-specific HLA-B- and HLA-C-restricted CD8+ T cells do not differ in polyfunctionality.Regulation of inflammatory chemokine receptors on blood T cells associated to the circulating versus liver chemokines in dengue fever.T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy.Broadening of the T-cell repertoire to HIV-1 Gag p24 by vaccination of HLA-A2/DR transgenic mice with overlapping peptides in the CAF05 adjuvantCD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/μL: The DART Trial STI SubstudyThe polyomavirus BK large T-antigen-derived peptide elicits an HLA-DR promiscuous and polyfunctional CD4+ T-cell response.Augmented HIV-specific interferon-gamma responses, but impaired lymphoproliferation during interruption of antiretroviral treatment initiated in primary HIV infection.T cell receptor binding affinity governs the functional profile of cancer-specific CD8+ T cellsSequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03:04 and modulate primary natural killer cell functionClonotype and repertoire changes drive the functional improvement of HIV-specific CD8 T cell populations under conditions of limited antigenic stimulation.Altered Memory Circulating T Follicular Helper-B Cell Interaction in Early Acute HIV Infection.Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection.HIV/AIDS vaccines: a need for new concepts?Treatment-dependent loss of polyfunctional CD8+ T-cell responses in HIV-infected kidney transplant recipients is associated with herpesvirus reactivationCTL quality and the control of human retroviral infections.Crosstalk between adaptive and innate immune cells leads to high quality immune protection at the mucosal bordersConserved HIV-1 Gag p24 Epitopes Elicit Cellular Immune Responses That Impact Disease Outcome.Mucosal memory CD8⁺ T cells are selected in the periphery by an MHC class I molecule.Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B.Fixing an irrelevant TCR alpha chain reveals the importance of TCR beta diversity for optimal TCR alpha beta pairing and function of virus-specific CD8+ T cells.Adenovirus 5- and 35-based immunotherapy enhances the strength but not breadth or quality of immunity during chronic SIV infection.Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine.No evidence for competition between cytotoxic T-lymphocyte responses in HIV-1 infection.
P2860
Q27347326-91186B38-3452-4838-891E-3DBD6271C694Q27487961-CCC35DA4-1B65-4C8E-ABE2-95F0CBA1299FQ30402467-DF9F5442-94CC-4103-8D71-2B54DA1E4ADDQ33565035-EC39F5BE-FCD9-4D41-BD0A-4DE560A8FEF8Q33640197-86DB0B62-C3F9-40C5-B125-BE5912016C6EQ33715758-4DADB3DE-05B3-4D11-AA26-E7132E9EDE1CQ33745356-CF465C7F-8332-45CD-A4CC-1B8D003227E8Q33869222-13C8E14C-3F69-4B3E-88A3-D5C14074CF2FQ33982883-75F6E487-728E-408F-B799-8D5691907CAAQ34047774-A55E39A2-9D4D-4D19-B177-1FEC28E5CD08Q34181287-35483BB7-8D40-44D5-9C58-2AA322780011Q34195857-00E4EBA2-DB5B-4472-AD87-63607E68ED35Q34344625-686980F1-3D0D-42B4-9A33-ED122B5FF876Q34510458-A099DD37-33AA-45B7-ACA0-57CE3B32F94FQ34730713-3FF51FF1-6EE6-4717-BEDA-CDF6B8D7CD11Q34730855-FF0F2C05-37AC-4DD8-8FB5-F616372E7174Q35066177-95311167-FB33-450A-93C7-7F07D453B7B6Q35175897-7D8FCAEE-49F2-4C8E-B00A-62836D83D90CQ35533181-595200CB-5575-4577-8A45-AE2E27C719E8Q35678598-A9B94FB7-19E8-4866-ABBB-4D9D0597889BQ35685446-D448ADFE-58D4-468D-A7C2-FADAF4813700Q36087130-E09E6D42-4B6A-4DF8-B06B-A8A8871CE2CBQ37273289-4CCAB5AA-27A4-46F5-8167-448EF1F10A2AQ37344236-81E18B7A-DB87-415D-88D8-4D1C60E7C05FQ37352087-9E98914A-6DB3-4187-AAFE-532D2392723DQ37543246-D3597CF8-A899-4AFA-969E-CE7E72AF00D9Q38086157-2D48BFD0-25DC-4EBF-A848-0CD2F9EECE61Q38736699-0C331085-8205-4D79-9EBA-19F587C2C2DDQ38772796-3451109B-F33D-4856-B97C-0ADC67207045Q41929341-D7E8405B-160D-40C8-A0CC-0056A8453A66Q45373917-0F2D77E5-DA48-4386-B7C4-241080383AE0Q51891172-B0443F20-9F80-4B30-9E8B-CF2D8AF5668BQ54247364-1FDFD297-2C0B-4EF7-AA79-72CA78AD3096Q55398991-BE466D97-DC0F-4A1F-BAB6-50DA62B06A04
P2860
Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Virological outcome after stru ...... f virus-specific CD8+ T cells.
@ast
Virological outcome after stru ...... f virus-specific CD8+ T cells.
@en
type
label
Virological outcome after stru ...... f virus-specific CD8+ T cells.
@ast
Virological outcome after stru ...... f virus-specific CD8+ T cells.
@en
prefLabel
Virological outcome after stru ...... f virus-specific CD8+ T cells.
@ast
Virological outcome after stru ...... f virus-specific CD8+ T cells.
@en
P2093
P2860
P356
P1433
P1476
Virological outcome after stru ...... f virus-specific CD8+ T cells.
@en
P2093
Catherine Rehm
Christian Yoder
Daniel C Douek
Diane Rock
Elizabeth Nies-Kraske
Elizabeth Urban
Jason M Brenchley
Julia A Metcalf
Julie Gumkowski
Laurie Lamoreaux
P2860
P304
P356
10.1128/JVI.02212-07
P407
P577
2008-01-30T00:00:00Z